Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of atorvastatin on the nitric oxide system in patients with type 2 diabetes and nephropathy
2010-019206-16Phase 2Completed
- Sponsor
- Medicinsk Forskningsafsnit, Regionshospitalet Holstebro
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Medicinsk Forskningsafsnit, Regionshospitalet Holstebro. Primary endpoints: Change in renal tubular sodium and water handling in response to L-NMMA, Change in central hemodynamics and 1 more. Started Apr 2010; status: completed.
02
Drugs
atorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2010-019206-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019206-16.